TY - JOUR
T1 - A Pictorial Essay of Immunotherapy
T2 - Complications that Internists Will See, Whether They Like it or Not
AU - Evens, Ashley
AU - Cyriac, George
AU - Jeong, Daniel
AU - Araujo, Cyrillo
AU - Gage, Kenneth
AU - Rose, Trevor
N1 - Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/7
Y1 - 2019/7
N2 - Immunotherapy agents for treatment of cancer have been investigated for decades, but effective agents have only recently been identified and are increasingly being used in multiple cancer types. There is growing recognition of adverse side effects in multiple organ systems mediated by dysregulation of the immune system, which can be exacerbated by comorbidities often found in cancer patients such as chronic lung disease, diabetes, and hypertension. As a result, internists and other nononcology clinicians are routinely encountering immunotherapy patients who present with a remarkably wide range of symptoms. Here, we present the radiographic manifestations of common side effects from immunotherapy agents. An accurate diagnosis is critical in these often-complex clinical settings in which the consequences of the underlying cancer and other comorbidities must be distinguished from the variable manifestations of treatment toxicity.
AB - Immunotherapy agents for treatment of cancer have been investigated for decades, but effective agents have only recently been identified and are increasingly being used in multiple cancer types. There is growing recognition of adverse side effects in multiple organ systems mediated by dysregulation of the immune system, which can be exacerbated by comorbidities often found in cancer patients such as chronic lung disease, diabetes, and hypertension. As a result, internists and other nononcology clinicians are routinely encountering immunotherapy patients who present with a remarkably wide range of symptoms. Here, we present the radiographic manifestations of common side effects from immunotherapy agents. An accurate diagnosis is critical in these often-complex clinical settings in which the consequences of the underlying cancer and other comorbidities must be distinguished from the variable manifestations of treatment toxicity.
KW - Antibodies
KW - Cancer
KW - Immune-related adverse effects
KW - Immunotherapy
UR - http://www.scopus.com/inward/record.url?scp=85064683849&partnerID=8YFLogxK
U2 - 10.1016/j.amjmed.2019.02.008
DO - 10.1016/j.amjmed.2019.02.008
M3 - Review article
C2 - 30849381
AN - SCOPUS:85064683849
SN - 0002-9343
VL - 132
SP - 808
EP - 815
JO - American Journal of Medicine
JF - American Journal of Medicine
IS - 7
ER -